Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anacor Pharmaceuticals Inc (NASDAQ:ANAC)

148.70
Delayed Data
As of Jul 30
 -1.56 / -1.04%
Today’s Change
16.31
Today|||52-Week Range
156.93
+361.09%
Year-to-Date

Today’s Trading

Previous close150.26
Today’s open150.00
Day’s range143.43 - 151.46
Volume619,584
Average volume (3 months)806,610
Market cap$6.6B
Dividend yield--
Data as of 07/30/2015

Growth & Valuation

Earnings growth (last year)-198.10%
Earnings growth (this year)+41.33%
Earnings growth (next 5 years)+61.30%
Revenue growth (last year)+20.07%
P/E ratioNM
Price/Sales65.86
Price/Book82.48

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...-7.67-2.85%
IDXXIDEXX Laboratories I...+4.88+7.34%
RCPTReceptos Inc-0.16-0.07%
TAROTaro Pharmaceutical ...-0.23-0.17%
Data as of 07/30/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$20.7M
Annual profit (last year)-$87.1M
Net profit margin-421.28%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Paul L. Berns
Chief Financial Officer &
Executive Vice President
Graeme Bell
Corporate headquarters
Palo Alto, California

Forecasts